Bausch + Lomb to acquire Xiidra, ‘front of eye’ assets from Novartis

Bausch + Lomb to acquire Xiidra, ‘front of eye’ assets from Novartis

Submitted by admin on June 30, 2023 - 10:10am
Source: 
Healio
News Tags: 
Bausch + Lomb
M&A
Novartis
Xiidra
dry eye disease
Headline: 
Bausch + Lomb to acquire Xiidra, ‘front of eye’ assets from Novartis
snippet: 
  • Bausch + Lomb will acquire Xiidra and other assets from Novartis for a transaction of up to $2.5 billion.
  • The deal is expected to close later this year.

Do Not Allow Advertisers to Use My Personal information